跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 49 条关于
“ADRIATIC”
全部
49
临床试验
28
药物
1
机构
0
资讯
20
去年
Durvalumab Shows Breakthrough Results in Limited-Stage Small Cell Lung Cancer Treatment
去年
Imfinzi Approved for Limited-Stage Small Cell Lung Cancer, Redefining Treatment
去年
CHMP Backs Durvalumab for Limited-Stage SCLC Following Chemoradiation Success
2年前
FDA Grants Priority Review and Breakthrough Therapy Designation to Imfinzi for Limited-Stage Small Cell Lung Cancer
去年
Durvalumab Shifts Decades Long SOC as First FDA-Approved Immunotherapy Regimen in LS-SCLC
去年
SCLC Treatment Landscape Evolves with Tarlatamab Approval and Promising Trial Results
11个月前
Durvalumab Shows Clinical Promise but Faces Cost-Effectiveness Hurdles in China's Small Cell Lung Cancer Treatment
去年
Inside ESMO 2024: Treatments, Trials, and Top HCPs on Social Media
2年前
Durvalumab Improves Survival in Limited-Stage Small Cell Lung Cancer Subgroups
2年前
Immunotherapy Advances Reshape Treatment Landscape for Small Cell Lung Cancer
第 1 页,共 2 页
上一页
下一页